Likewise, no significant alterations were detected when evaluating circulating CD4+ Treg cells’ function by IL-10 and TGFβ mRNA expression, indicating that there are no functional defects in this cell subset in HCC or CCA patients. This evidence concerns the gene TGFB1 and cholangiocarcinoma.